Dr. Mitul Gandhi
Claim this profileVirginia Cancer Specialists
Studies Lymphoma
Studies Leukemia
17 reported clinical trials
31 drugs studied
Area of expertise
1Lymphoma
Stage I
Stage IV
Stage III
2Leukemia
BCR-ABL1 positive
BCR-ABL1 e13a2 positive
BCR-ABL1 e14a2 positive
Affiliated Hospitals
Clinical Trials Mitul Gandhi is currently running
Pirtobrutinib + VR
for Chronic Lymphocytic Leukemia
The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up to five years.
Recruiting2 awards Phase 3
Cema-cel
for B-Cell Lymphoma
This is a randomized, open-label study in adult patients who have completed standard first line of therapy for large B-cell lymphoma (LBCL) and achieved a complete response or partial response suitable for observation, but who have minimal residual disease (MRD) as detected by the Foresight CLARITY™ Investigational Use Only (IUO) MRD test, powered by PhasED-Seq™. The purpose of the trial is to assess the efficacy and safety of consolidation with cemacabtagene ansegedleucel (cema-cel), an allogeneic CD19 CAR T product, as compared to standard of care observation. The study is conducted in 2 consecutive parts that will be enrolled continuously. In Part A of the study, participants with MRD are randomized to one of two treatment arms or an observation arm. Treatment includes cema-cel following a lymphodepletion regimen of fludarabine and cyclophosphamide administered with or without the anti-CD52 monoclonal antibody, ALLO-647. Part A will culminate with the selection of the lymphodepletion regimen to advance to Part B. Part B will evaluate the selected lymphodepletion regimen followed by cema-cel as compared with observation.
Recruiting1 award Phase 25 criteria
More about Mitul Gandhi
Clinical Trial Related2 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Mitul Gandhi has experience with
- Rituximab
- Tazemetostat
- Lenalidomide
- LOXO-305
- Venetoclax
- Selinexor
Breakdown of trials Mitul Gandhi has run
Lymphoma
Leukemia
Plasma Cell Neoplasms
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mitul Gandhi specialize in?
Mitul Gandhi focuses on Lymphoma and Leukemia. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are Stage IV.
Is Mitul Gandhi currently recruiting for clinical trials?
Yes, Mitul Gandhi is currently recruiting for 6 clinical trials in Gainesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Mitul Gandhi has studied deeply?
Yes, Mitul Gandhi has studied treatments such as Rituximab, Tazemetostat, Lenalidomide.
What is the best way to schedule an appointment with Mitul Gandhi?
Apply for one of the trials that Mitul Gandhi is conducting.
What is the office address of Mitul Gandhi?
The office of Mitul Gandhi is located at: Virginia Cancer Specialists, Gainesville, Virginia 22155 United States. This is the address for their practice at the Virginia Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.